» Articles » PMID: 10557073

Signal Transduction Elements of TC21, an Oncogenic Member of the R-Ras Subfamily of GTP-binding Proteins

Overview
Journal Oncogene
Date 1999 Nov 11
PMID 10557073
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

TC21 is a Ras-like GTPase with high oncogenic potential that is found mutated in some human tumors and overexpressed in breast cancer cell lines. We have conducted cellular and biochemical studies in order to understand the role of this protein in signal transduction and to unveil the signaling elements that participate in the TC21 pathway. Using gene transfer experiments, we demonstrate here that the TC21 oncogene can induce both cellular transformation in mouse fibroblasts and neuronal-like differentiation in rat PC12 cells. Interestingly, the proto-oncogenic version of TC21 shows also a lower, but significant, activity in both biological processes. We also demonstrate that the similarity of the cellular responses induced by TC21 and Ras derive from the utilization of overlapping pathways. Thus, the exchange of guanosine nucleotides in wild type TC21 is catalyzed by Ras exchange factors. Moreover, TC21 binds physically to c-Raf-1 in a GTP-dependent manner. Finally, overexpression of TC21G23V in NIH3T3 cells results in the activation of c-Raf-1 and the MAPK and the JNK branches of serine/threonine cascades. From these results, we conclude that TC21 promotes Ras-like responses in diverse cell types due to the use of overlapping, if not identical, signaling elements of the Ras oncogenic pathway.

Citing Articles

Longitudinal plasma proteome profiling reveals the diversity of biomarkers for diagnosis and cetuximab therapy response of colorectal cancer.

Li Y, Wang B, Yang W, Ma F, Zou J, Li K Nat Commun. 2024; 15(1):980.

PMID: 38302471 PMC: 10834432. DOI: 10.1038/s41467-024-44911-1.


Mice Overexpressing Wild-Type Are a Novel Model for Preclinical Testing of Anti-Chronic Lymphocytic Leukemia Therapies.

Hortal A, Villanueva A, Arellano I, Prieto C, Mendoza P, Bustelo X Cancers (Basel). 2023; 15(24).

PMID: 38136362 PMC: 10742337. DOI: 10.3390/cancers15245817.


Transfection of Sponge Cells and Intracellular Localization of Cancer-Related MYC, RRAS2, and DRG1 Proteins.

Dominko K, Talajic A, Radic M, Vidacek N, Vlahovicek K, Herak Bosnar M Mar Drugs. 2023; 21(2).

PMID: 36827160 PMC: 9964533. DOI: 10.3390/md21020119.


Characterization of mutant versions of the R-RAS2/TC21 GTPase found in tumors.

Clavain L, Fernandez-Pisonero I, Movilla N, Lorenzo-Martin L, Nieto B, Abad A Oncogene. 2022; 42(5):389-405.

PMID: 36476833 PMC: 9883167. DOI: 10.1038/s41388-022-02563-9.


Overexpression of wild type RRAS2, without oncogenic mutations, drives chronic lymphocytic leukemia.

Hortal A, Oeste C, Cifuentes C, Alcoceba M, Fernandez-Pisonero I, Clavain L Mol Cancer. 2022; 21(1):35.

PMID: 35120522 PMC: 8815240. DOI: 10.1186/s12943-022-01496-x.